医学
危险系数
无症状的
四分位间距
蒽环类
内科学
置信区间
临床终点
心力衰竭
弗雷明翰风险评分
临床试验
癌症
乳腺癌
疾病
作者
Borja Rivero Santana,Jesús Saldaña García,Juan Caro‐Codón,Pilar Zamora,Pedro Moliner,A. Martínez Monzonís,Eduardo Zatarain‐Nicolás,Carlos Álvarez-Ortega,Pilar Gómez‐Prieto,Sònia Pernas,Isabel Rodrı́guez,Antonio Buño Soto,Rosalía Cádenas,Patricia Palacios Ozores,Sara Ramírez,María Merino Salvador,Silvia Valbuena,Lucía Fernández Gassó,V Juarez,Andrea Severo Sánchez
标识
DOI：10.1093/eurheartj/ehae496
摘要
Baseline cardiovascular toxicity risk stratification is critical in cardio-oncology. The Heart Failure Association (HFA) and International Cardio-Oncology Society (ICOS) score aims to assess this risk but lacks real-life validation. This study validates the HFA-ICOS score for anthracycline-induced cardiovascular toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
赫枫
高大凌寒
剑指东方是为谁
bc
余味
非而者厚
andrele
VDC
back you up
核桃
飘零无边
Singularity
MchemG
斯寜
遇上就这样吧
竹筏过海
爱静静
Gummybear
淡然的舞仙
皖公网安备34019202002308
